Filter
1560
Text search:
medicines
financing
Featured
Recommendations
132
New Publications
486
Language
Document type
No document type
855
Studies & Reports
320
Guidelines
140
Strategic & Response Plan
126
Manuals
69
Fact sheets
21
Situation Updates
12
Training Material
7
Resource Platforms
4
Infographics
4
Brochures
2
Countries / Regions
Global
105
Kenya
65
Uganda
46
Sierra Leone
43
Liberia
41
Ethiopia
37
Ghana
37
Africa
37
Western and Central Europe
36
India
35
Myanmar / Burma
34
Nigeria
33
Zambia
29
Ukraine
29
Bangladesh
26
Rwanda
25
South Africa
25
Malawi
25
Nepal
23
Tanzania
23
Namibia
20
Eastern Europe
20
Latin America and the Carribbean
19
Asia
15
Mozambique
13
Congo, Democratic Republic of
12
Philippines
12
East and Southern Africa
12
Cambodia
11
Zimbabwe
10
Indonesia
10
Lesotho
10
West and Central Africa
10
Middle East and North Africa
10
South–East Asia Region
10
Guinea
9
Botswana
9
Senegal
7
Cameroon
7
Haiti
7
Syria
7
Burkina Faso
6
Eastern Europe and Central Asia
6
Venezuela
6
Pakistan
5
Thailand
5
Eswatini/ Swaziland
5
Vietnam
5
Somalia
4
Sudan
4
Benin
4
Western Pacific Region
4
Tajikistan
4
Russia
4
North America
4
South Sudan
3
Jordan
3
Afghanistan
3
North Macedonia
3
Paraguay
3
Laos
3
Georgia
3
Gambia
2
China
2
Central African Republic
2
Ecuador
2
Bolivia
2
Libya
2
Yemen
2
Palestine
2
Albania
2
Southern Africa
2
Timor Leste/ East Timor
2
Qatar
2
Moldova
2
Kyrgyzstan
2
Jamaica
2
Mali
1
Saudi Arabia
1
Iraq
1
Germany
1
Lebanon
1
Egypt
1
Chad
1
Papua New Guinea
1
Peru
1
Brazil
1
Switzerland
1
Colombia
1
Sri Lanka
1
Chile
1
Other region
1
Djibouti
1
Armenia
1
Mongolia
1
Bulgaria
1
Iran
1
Uzbekistan
1
Kazakhstan
1
Turkmenistan
1
Japan
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
694
Public Health
113
Clinical Guidelines
80
Women & Child Health
60
Key Resources
48
Pharmacy & Technologies
10
Capacity Building
7
Toolboxes
HIV
144
TB
130
COVID-19
107
AMR
63
Health Financing Toolbox
60
Mental Health
53
Global Health Education
47
Pharmacy
46
Planetary Health
35
NCDs
31
Caregiver
29
Disability
28
Malaria
28
Conflict
25
NTDs
24
Ebola & Marburg
23
Rapid Response
18
Refugee
12
2.0 Rapid Response
11
Natural Hazards
10
Polio
6
Cholera
5
Zika
3
Specific Hazards
1
Social Ethics
1
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and
...
The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study
The Malawian government recently introduced cost-covering consultation fees for self-referral patients in tertiary public hospitals. Previously, patients received medicines free of charge in government-owned health facilities, but must pay elsewhere
...
As a deliverable of the G20 Health and Finance Ministers' Meeting on June 28, 2019, ministers confirmed their commitment to this "G20 Shared Understanding."
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential
...
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential
...
This report reviews and analyses the Affordable Medicines Programme, which was introduced in Ukraine in April 2017 to provide patients with improved access to 23 outpatient medicines for the treatme
...
Agodokpessi et al. Journal of Pharmaceutical Policy and Practice (2015) 8:12DOI 10.1186/s40545-015-0033-7
Benin established a revolving drug fund (RDF) for essential asthma medicines in 2008. We evaluated
the operation of the RDF and assessed wh
...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Securing a minimum of financial resources permitting to bring the full range of critical health services to all people constitutes a fundamental human right and an indispensable condition for human dignity. The model outlined here demonstrates that it is within our reach to close the
...
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Me
...
This report was developed by the WHO TB Vaccine Accelerator Finance and Access working group, co-led by WHO, Gavi and the Government of South Africa. It sets out the working group’s shared vision for equitable access to novel TB vaccines and will advance a shared understanding of the current lands
...
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS function
...
